AzTrials
AzTrials

Type 1 DiabetesSUMMIT1NCT05671679

Supporting Meal Management in Type 1 Diabetes

A study testing SNAQ app and Traditional carbohydrate counting in people with Type 1 Diabetes, run by Lia Bally at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Type 1 Diabetes
What is being tested?
SNAQ app and Traditional carbohydrate counting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteSwitzerland
Study dates
27 Mar 2023to 8 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Written informed consent
  • Adults (aged 18 years or older)
  • Type 1 diabetes (as defined by World Health Organization (WHO) for at least 12 month)
  • Current use of a commercial hybrid closed-loop system
  • HbA1c≤12% (measured within the past 3 months)
  • Willing to use the SNAQ app on a daily basis for over 3 weeks
  • The participant is willing to follow study specific instructions and share their treatment data with the study team

Who cannot join

  • Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
  • Previous use of SNAQ app for more than 5 days within the past 3 months
  • Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
  • Severe visual impairment
  • Severe hearing impairment
  • Lack of reliable telephone facility for contact
  • Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results
  • Participant not proficient in German

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital

    Bern, Canton of Bern, 3010

Other trials in Switzerland

About this study

Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation.

Read the detailed description

Diet and physical activity are critically important in the lifestyle of people with type 1 diabetes. When diagnosed with the disease, people with type 1 diabetes are educated about nutritional goals and how to estimate nutritional content of food. Carbohydrates are the food component with the greatest impact on blood glucose levels and typical sources in the diet include starches, some vegetables, fruits, dairy products and sugars . Thus, people with type 1 diabetes are primarily being trained to estimate the carbohydrate content of food, a task that is also referred to as carbohydrate counting. Different methods can be used to count carbohydrate in food and drink. These include reading the nutritional labels, consulting reference books or websites, carrying a database on a personal digital assistant or using exchange tables which provides the carbohydrate content for typical serving sizes (e.g. 1 slice of bread). While nutritional information can be accessed through the above mentioned methods, the quantification of the portion sizes (if not indicated on the food package) requires the additional use of scale or measuring vessel. Given the required effort and time investment related to these methods, the great majority of people with type 1 diabetes count carbohydrates by visual estimation and experience. As a consequence, people's estimate often deviate substantially from ground truth values and average carbohydrate estimation errors reported in the literature are 20% or higher.

Of note, more than 60% of individuals with diabetes report having trouble with carbohydrate counting, despite their awareness on its importance . Even in patients who are confident in applying carbohydrate counting, the daily task is perceived as major burden of diabetes self-management.

Since carbohydrate counting is particularly demanding when eating fresh, non-packaged foods, a concerning trend towards unhealthy dietary choices with preference of prepackaged foods (with accessible nutrition facts) over whole foods is increasingly observed in people with type 1 diabetes. This is paralleled by an increasing prevalence of overweight and obesity in the type 1 diabetes population.

Thus, even with the latest hybrid closed-loop insulin delivery technologies, adequate nutrition knowledge remains a cornerstone for satisfactory glucose control, metabolic health, and prevention of diabetes-related complications and comorbidities.

With the development of new technologies embedded in modern smartphones (i.e. depth sensors), image-based methods to support food assessment have become widely available. Of particular use is the employment of well-established computer vision methodologies to estimate the quantity of food. When combined with food-recognition technologies and information from nutritional databases, a proposition of the nutritional content (e.g. carbohydrates, fat, proteins, fibres) can be made to the user on the basis of captured images and obviates the need for error prone visual estimations and mental calculations. Several such applications have become available and can support monitoring the diet as part of lifestyle management.

Insights from a recent online survey suggest that a high proportion of people with type 1 diabetes believe that such new technologies for meal management could facilitate their daily self-management and would be interested in using such technology. Moreover, according to a recent study, such digital tools may promote diabetes education and food literacy which may particularly benefit those with a lower education level and with a history of depression.

Amongst several options (e.g. Foodvisor, Calorie-Mamma, Lifesum) for image-based food tracking and analysis, SNAQ is one of the most commonly used app in people with type 1 diabetes. Up to date, more than 40000 users have downloaded the SNAQ app in their phones, of which 2,500 are living in Switzerland.

The investigators have previously demonstrated that the system estimates the macronutrient content of real meals with satisfying accuracy.

However, evidence with regards to the effect of the food analysis on daily self-management of people with type 1 diabetes (e.g. glucose control, meal patterns, perceived benefits) is currently lacking. The investigators therefore aim to address these aspects in a randomized-controlled study contrasting the use of the SNAQ app with people's traditional meal management techniques.

Conditions
Type 1 Diabetes
Being tested
SNAQ app, Traditional carbohydrate counting
Keywords
Carbohydrates, Continuous glucose measurement, Closed-loop systems, Type 1 Diabetes, Hyperglycaemia, Hypoglycaemia
Medical subject headings
Diabetes Mellitus, Type 1, Hyperglycemia, Hypoglycemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SNAQ appOther

    SNAQ is a smartphone food analysis app that estimates the macronutrient content of a meal, based on a single image. The app first determines meal content in terms of food components with input from the user to correct or add further components (e.g. foods, ingredients, sauces, herbs or seasonings). Then, the total macronutrient and energy content of the meal is determined based on the estimated volume and information from a nutritional database. Of note, the application also allows for assessing nutritional content of packaged foods by means of a barcode scanning function. The user can always adapt proposed nutritional contents at their own discretion. Meal macronutrients alongside the food pictures are collected in a detailed log which allows users to review their dietary choices. The product is not conceived by its manufacturer to be used for medical purposes and can thus not be considered a medical device.

  • Traditional carbohydrate countingOther

    Patients will follow their traditional methods of carbohydrate counting during the control period. In addition to assess sustainability of the intervention, following the control period, the control group will also go an intervention period of 3 weeks using the SNAQ App.

Study groups in NCT05671679
Study groupRoleWhat they receive
InterventionExperimentalThe intervention group will use SNAQ app for the first 3 weeks (baseline to V1) of the study.
Receives: Other: SNAQ app
ControlActive comparatorThe control group will continue estimating the carbohydrate count using their traditional methods for the first three weeks of the study (baseline to V1).
Receives: Other: Traditional carbohydrate counting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of time with sensor glucose in the target range

    Percentage of time with sensor glucose in the target range between 3.9 to 10.0mmol/L, %

    Measured: 3-week intervention period (Day 1 to Day 21)

Secondary outcomes (11)
  1. Percentage of time with sensor glucose in hyperglycaemia

    Percentage of time with sensor glucose in the target range above 10.0mmol/L, %

    Measured: 3-week intervention period (Day 1 to Day 21)

  2. Percentage of time with sensor glucose in hypoglycaemia

    Percentage of time with sensor glucose in the target range below 3.9 mmol/L, %

    Measured: 3-week intervention period (Day 1 to Day 21)

  3. Percentage of postprandial time with sensor glucose in target range

    Percentage of postprandial time with sensor glucose in target range between 3.9 to 10.0 mmol/L

    Measured: 3-week intervention period (Day 1 to Day 21)

  4. Percentage of postprandial time with sensor glucose in hyperglycaemia

    Percentage of postprandial time with sensor glucose in the target range above 10.0mmol/L, %

    Measured: 3-week intervention period (Day 1 to Day 21)

  5. Percentage of postprandial time with sensor glucose in hypoglycaemia

    Percentage of postprandial time with sensor glucose in the target range below 3.9 mmol/L, %

    Measured: 3-week intervention period (Day 1 to Day 21)

  6. Sustainability: Change in percentage of time with sensor glucose in the target range

    Sustainability: Change in the percentage of time with sensor glucose in target range (3.9 to 10.0mmol/L, %)

    Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention

  7. Sustainability: Change in the percentage of time with sensor glucose in hyperglycaemia

    Sustainability: Change in percentage of time with sensor glucose above target range (>10.0mmol/L, %)

    Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention

  8. Sustainability: Change in the percentage of time with sensor glucose in hypoglycaemia

    Sustainability: Change in percentage of time with sensor glucose below target range (<3.9mmol/L, %)

    Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention

  9. Sustainability: Change in the percentage of time with postprandial sensor glucose in target range

    Sustainability: Change in the percentage of time with postprandial sensor glucose in target range (3.9 to 10.0mmol/L, %)

    Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention

  10. Sustainability: Change in the percentage of time with postprandial sensor glucose in hyperglycaemia

    Sustainability: Change in the percentage of time with postprandial sensor glucose above target range (>10.0mmol/L, %)

    Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention

  11. Sustainability: Change in the percentage of postprandial time with sensor glucose in hypoglycaemia

    Sustainability: Change in the percentage of postprandial time with sensor glucose below target range (<3.9mmol/L, %)

    Measured: 2-3-weeks before period with intervention compared with the 3 weeks after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2023
  2. Study start27 Mar 2023
  3. Primary completion8 May 2024
  4. Study completion8 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study will follow a randomized two-arm parallel design. Study visits will be done remotely via video calls or in-clinic when coinciding with usual care appointments. Following a baseline visit and before randomization, baseline characteristics and medical history of the participants will be collected (as detailed in section 4.3). Following randomization, the intervention group will use SNAQ app for the first 3 weeks while the control group will proceed without any modification/intervention by the study team. After the first 3 weeks, the control group will undergo 3 weeks of SNAQ app use (weeks 4-6). At the end of their respective SNAQ app periods (weeks 4-6 for the intervention group and weeks 7-9 for the control group), both groups will discontinue the use of SNAQ app for 3 weeks to assess sustainability of potential effects. Finally, both groups will be offered to use SNAQ app for 3 additional weeks as per their preference (follow-up period).
Masking
None (open label)
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05671679
Sponsor's protocol ID
SUMMIT1
Acronym
SUMMIT1
Status last verified
Jun 2024
First submitted
22 Dec 2022
Last updated
11 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymised individual participant data will be shared after inquiry via a validated sharing platform (yet to be defined). Anonymised data packages will be available once the final study results are published in a peer-reviewed journal.

Questions about this trial

What is this clinical trial studying?

A study testing SNAQ app and Traditional carbohydrate counting in people with Type 1 Diabetes, run by Lia Bally at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of time with sensor glucose in the target range (time frame: 3-week intervention period (Day 1 to Day 21)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in